Charting the Path of Success: A Deep Dive into Microspheres - A Comprehensive Review for Researchers Uncovering Triumphs, Innovations and Future Directions

 

Shashank R Gowda, Hindustan Abdul Ahad*, Edukulla Satheesh Kumar, Athmika Sreedhara, Ranjitha Venkatesh, Amisha

Department of Pharmaceutics, RR College of Pharmacy, Chikkabanavara, Bangalore - 560090, Karnataka, India.

 

ABSTRACT:

This comprehensive review offers an in-depth exploration of the multifaceted role of microspheres within the realm of drug delivery systems. Delving into various aspects including fabrication methods, evaluation techniques, and recent advancements, the review provides a thorough understanding of how microspheres contribute to the field. One key highlight is the versatility exhibited by microspheres in ensuring prolonged drug release across different administration routes such as oral, nasal, and buccal. By compiling information on the diverse types of microspheres, the polymers employed in their fabrication, and the methodologies utilized for their preparation, the review offers valuable insights into the factors influencing their efficiency. Furthermore, it discusses parameters for evaluating microsphere performance, shedding light on critical considerations in their development and application. Notably, the review emphasizes the significant impact of microspheres on enhancing solubility, absorption rates, and overall bioavailability of drugs. This attribute proves particularly beneficial in the management of chronic disorders, where sustained release and improved patient compliance are paramount. Overall, this review underscores the pivotal role played by microspheres in advancing drug delivery technology and their potential to revolutionize treatment strategies across diverse medical domains.

 

 

INTRODUCTION:

A revolutionary drug delivery system is a fresh strategy that applies cutting-edge concepts, fresh technology, and inventive methods to deliver active compounds at a safe concentration that achieves the intended pharmacological effect.

 

These innovative systems can maintain the plasma drug concentration in a controlled manner, improving the drug's performance in terms of safety, efficacy, and patient compliance compared to traditional dosage forms. Tailoring each system to the specific properties of the drug and the physiological characteristics of the target tissue or organ is crucial for optimal therapeutic efficacy. Examples include nanoparticles, which encapsulate and protect drugs, delivering them precisely to target sites; liposomes, which encapsulate both hydrophilic and hydrophobic drugs for efficient delivery; transfersomes, which pass through narrow constrictions for effective transdermal delivery; polymeric micelles, which solubilize poorly water-soluble drugs for enhanced bioavailability; hydrogels, which swell to release drugs in response to specific stimuli; implants, which provide steady drug release over extended periods; and microneedles, which offer a minimally invasive alternative for precise dosing. By leveraging these advanced systems, it is possible to achieve more effective and safer treatments, enhance patient adherence to therapy, and address the limitations of conventional drug administration methods. It becomes essential to transport the drug to the target tissue in the ideal amount throughout the appropriate period with minimum toxicity and minimal side effects to achieve maximal therapeutic efficacy. A medicinal ingredient can be delivered to the target site in several ways using prolonged controlled release techniques. One such method is using microspheres as drug carriers¹.

 

Microspheres are tiny, spherical particles with dimensions between one and a thousand micrometers, also known as microparticles. Many synthetic and natural materials can be used to create microspheres^2-4. A lot of research has been done on the usage of microspheres in drug transport. Different polymers have been used to create microspheres, which have then been evaluated for specific uses. By maintaining a constant plasma concentration, the entire dose and side effects can eventually be reduced. Microspheres come in two varieties: micromatrices and microcapsules. In micromatrices, the entrapped material is distributed throughout the microsphere matrix, while in microcapsules, the entrapped material is encircled by discrete capsule walls⁵.

 

ADVANTAGES OF MICROSPHERES:

The merits of microspheres were as follows.

·       Boosts bioavailability.

·       Due to their small and spherical nature, they can be injected into the body.

·       Enhancement of a biological half-life is possible with microspheres.

·       Enhances patient adherence by decreasing the frequency of doses.

·       Improved medication usage can decrease the occurrence or degree of adverse events and increase bioavailability.

·       It is possible to lessen dosage frequency and side effects.

·       It is possible to lower first-pass metabolism.

·       Reduced gastric discomfort, improved patient compliance, and sustained and continuous therapeutic benefits are all possible with microspheres.

·       The medicine's disagreeable taste and smell can be covered up.

·       The potency of poorly soluble substances is boosted when the microsphere's surface area is increased due to its decreased size.

 

DISADVANTAGES OF MICROSPHERES:

The demerits of microspheres were as follows^{6, 7}.

·       The degradation products of the polymer matrix, generated in reaction to heat, hydrolysis, oxidation, solar radiation, or biological agents, and their effects on the environment.

·       The destiny of the polymer matrix and its impact on the surroundings.

·       The expenses associated with the materials and processing of the controlled release preparation are significantly greater than those of standard formulations.

·       The fate of polymer additives like fillers, stabilizers, plasticizers, and antioxidants.

·       There's little reproducibility.

·       Variations in temperature, pH, solvent addition, evaporation/agitation, and other process variables may impact the stability of core particles.

 

CHARACTERISTICS OF MICROSPHERES:

The microencapsulation process can be used to incorporate solid, liquid, or gas into one or more polymeric coverings. The diverse techniques utilized for different microsphere preparations depend on factors such as particle size, drug delivery route, period of release, and characteristics like rpm, degree of cross-linking, evaporation time, and co-precipitation. Certain requirements should be met when preparing microspheres^8-10.

 

·       Biocompatibility with regulated biodegradability.

·       Controllable release of the active reagent over an extended period of time.

·       Particle size and dispersibility in aqueous injection vehicles are regulated.

·       The capacity to include suitably high drug concentrations.

·       The stability of the product following synthesis with a clinically acceptable shelf life.

 

TYPES OF MICROSPHERES:

Microspheres are classified into different types¹¹ (Figure 1). They are

 

Fig.1. Different types of microspheres

 

Bioadhesive microsphere:

Adhesion refers to the process where a medication adheres to a membrane, utilizing the water-soluble properties of water-soluble polymers. Adherence describes the sticking or attachment of a drug delivery system to a mucosal membrane, such as buccal, nasal, ocular, or rectal membranes. This type of microsphere can provide superior therapeutic effects and a longer residence period at the target region^12,13.

 

Magnetic Microspheres:

Since this type of delivery mechanism localizes medication to the disease site, it is crucial. Here, a lower quantity of magnetically focused medication can replace a larger quantity of freely circulating medication. Magnetic microspheres incorporate compounds like chitosan and dextran, which exhibit magnetic responses when exposed to a magnetic field. They are categorized into two types^14,15.

 

Therapeutic magnetic microspheres: 

These magnetic microspheres are utilized specifically to deliver chemotherapeutic agents to liver tumors. By harnessing magnetic fields, these microspheres can be directed precisely to the site of the tumor within the liver, enhancing the concentration of the chemotherapy drugs at the target location while minimizing systemic exposure and side effects. Apart from chemotherapeutic agents, this system can also be adapted to target drugs such as proteins and peptides. By attaching these therapeutic compounds to the magnetic microspheres, they can similarly be guided and concentrated to specific tissues or organs using external magnetic fields, thereby improving treatment efficacy and reducing off-target effects. This targeted delivery approach holds promise for enhancing the treatment outcomes of various diseases, including cancers and other localized disorders^16,17.

 

Diagnostic microspheres: 

These magnetic microspheres serve multiple purposes, including imaging liver metastases and distinguishing bowel loops from other abdominal structures by forming nano-sized particles of superparamagnetic iron oxides. In the context of floating types, their low bulk density compared to gastric fluid allows them to remain buoyant in the stomach without affecting gastric emptying rates. This design enables controlled release of drugs at a desired rate, with the system floating on gastric contents, thereby prolonging gastric residence time and reducing fluctuations in plasma concentration. Additionally, this approach minimizes the risk of dose dumping, enhances the duration of drug effects, and reduces the frequency of dosing required^18,19.

 

Radioactive microspheres:

The subgroup of microspheres that interact radioactively is generally handled similarly to non-radioactive microspheres. However, radioactive microspheres always incorporate one or more radioisotopes alongside the matrix material that defines the microsphere and provides its targeting properties to specific tissues or organs. Even in small quantities, radioactive microspheres can deliver substantial doses of radiation precisely to a targeted region without significantly affecting surrounding healthy tissue. This targeted radiation delivery approach is particularly useful in therapeutic applications where localized treatment is necessary while minimizing systemic side effects^20,21.

 

Polymeric microspheres:

Polymeric microspheres encompass two primary categories: biodegradable polymeric microspheres and synthetic polymeric microspheres. Biodegradable varieties are crafted from natural or synthetic polymers that break down through biological processes, ensuring they degrade into harmless byproducts. These are ideal for sustained drug delivery, minimizing the need for removal post-use. In contrast, synthetic polymeric microspheres are composed of polymers resistant to degradation under physiological conditions, maintaining stability for prolonged release applications. Each type offers distinct advantages, serving as versatile platforms for drug delivery, imaging agents, and various biomedical uses^22,23.

 

Biodegradable:

Polymeric microspheres utilize natural polymers like starch for their biodegradability, biocompatibility, and bioadhesive properties. These polymers enhance residence time by swelling significantly in aqueous environments, forming a gel that adheres to mucous membranes. The concentration of polymer influences the rate and extent of drug release, facilitating sustained release patterns for controlled therapeutic effects. This approach is advantageous for optimizing drug delivery, ensuring targeted and prolonged release while minimizing dosing frequency²⁴. This type of microsphere shows prolonged residence time at the site of application²⁵.

 

Synthetic polymeric microspheres:

Synthetic polymeric microspheres find extensive use in clinical applications, serving as bulking agents, fillers, embolic particles, and drug delivery vehicles due to their safety and biocompatibility. However, a significant drawback is their tendency to migrate from the injection site, posing risks such as embolism and potential organ damage. Despite their versatility, careful consideration and precise application techniques are crucial to mitigate these risks and ensure their safe and effective use in medical treatments²⁶.

 

Materials used in the microsphere formulation:

Both synthetic and natural polymers are used in the formulation of microspheres²⁷.

 

Non-biodegradable synthetic polymers:

These synthetic polymeric microspheres include materials such as Polymethyl methacrylate (PMMA), acrolein glycidyl methacrylate, and epoxy polymers. They are utilized in various clinical applications for their versatility as bulking agents, fillers, embolic particles, and drug delivery vehicles. Despite their effectiveness, a notable concern with these microspheres is their potential to migrate from the injection site, which can lead to risks like embolism and organ damage. Careful application and monitoring are essential to ensure their safe and effective use in medical procedures.

 

Biodegradable polymers:

These synthetic polymeric microspheres include lactides, glycolides, and their copolymers, as well as polyalkyl cyanoacrylates and polyanhydrides. They are widely utilized in clinical applications for their biodegradability, controlled release properties, and biocompatibility. These materials serve various purposes such as drug delivery vehicles, tissue engineering scaffolds, and implants. However, like other synthetic microspheres, careful consideration is necessary to prevent potential risks such as migration from the injection site and associated complications like embolism.

 

Natural polymers:

These natural polymeric microspheres include proteins such as albumin, gelatin, and collagen, as well as carbohydrates like agarose, carrageenan, chitosan, and starch. Additionally, chemically modified carbohydrates such as polydextran and poly starch are also utilized. These materials are valued for their biocompatibility, biodegradability, and ability to facilitate controlled drug release. They find applications in drug delivery systems, tissue engineering, and biomedical research, offering versatile platforms for therapeutic and diagnostic purposes.

 

TECHNIQUES OF PREPARATION OF MICROSPHERE:

The choice of technique depends upon the nature of the polymer as well as the nature of the drug and the duration of therapy²⁸.Several critical factors influence the development and application of polymeric microspheres (Figure 2):

 

§  The polymer's molecular weight affects its biodegradability, mechanical properties, and drug release kinetics.

§  The ratio of polymer to drug determines the loading capacity and release profile of the microspheres.

§  Reproducibility in manufacturing ensures consistency in drug delivery and therapeutic efficacy.

§  Stability considerations include the shelf life and degradation profile of the microspheres.

§  The required particle size influences biodistribution, targeting efficiency, and drug release kinetics.

§  The total mass of polymers and pharmaceuticals determines the overall drug loading capacity and dosage form suitability.

 

Fig.2. Different methods of preparation of microsphere

 

These factors collectively impact the design, performance, and application of polymeric microspheres in various biomedical and pharmaceutical contexts, from controlled drug delivery to tissue engineering.

 

Single emulsion technique:

Several proteins and carbohydrates are prepared using the emulsion cross-linking technique. Initially, natural polymers are dissolved in an aqueous medium and then dispersed into a non-aqueous (oil) phase. The subsequent step involves cross-linking, which can be achieved through two methods: chemical cross-linking, utilizing chemical agents to form covalent bonds between polymer chains for enhanced stability and controlled drug release; and physical cross-linking, relying on physical interactions like hydrogen bonding or electrostatic forces to stabilize the polymer network without chemical additives, preserving the biological activity of sensitive compounds. These methods are crucial in the development of polymeric microspheres designed for controlled drug delivery and various biomedical applications.

 

Cross-linking by heat:

It involves adding the polymer dispersion into heated oil, but it is not suitable for thermolabile drugs due to the potential for drug degradation under elevated temperatures.

 

Chemical cross-linking agents:

Chemical cross-linking agents, such as formaldehyde, di acid chloride, and glutaraldehyde, are used to prepare microspheres. However, this method has the drawback of exposing active ingredients to chemicals during preparation, followed by processes like centrifugation, washing, and separation. For instance, chitosan solution in acetic acid is added to liquid paraffin containing a surfactant, forming a water-in-oil (w/o) emulsion. Glutaraldehyde 25% solution is commonly used as a cross-linking agent to prepare microspheres, such as those containing metformin hydrochloride. These methods are employed to control the release profile and enhance the stability of drugs encapsulated within microspheres.

 

DOUBLE EMULSION TECHNIQUE:

The double emulsion method of microsphere preparation involves creating a multiple or double emulsion, typically of type water-in-oil-in-water (w/o/w), which is particularly suited for encapsulating water-soluble drugs, peptides, proteins, and vaccines. This versatile technique can utilize both natural and synthetic polymers. Initially, an aqueous protein solution containing the active constituents is dispersed within a lipophilic, organic continuous phase, usually consisting of a polymer solution. The primary emulsion is then sonicated and added to an aqueous solution of polyvinyl alcohol (PVA), forming a stable double emulsion. This emulsion is subsequently processed to remove the solvent through methods such as evaporation or extraction. The double emulsion solvent evaporation or extraction method has been successfully employed to encapsulate various hydrophilic drugs like luteinizing hormone (LH-RH) agonists, vaccines, proteins, peptides, and conventional molecules within microspheres, ensuring controlled release and enhanced stability for therapeutic applications²⁹.

 

POLYMERIZATION TECHNIQUE:

Mainly, two techniques used for the preparation of microspheres are classified as:

 

Normal polymerization:

In bulk polymerization, a monomer or a mixture of monomers, along with an initiator or catalyst, is heated to initiate polymerization. The resulting polymer can be molded into microspheres, with drug loading achieved by adding the drug during polymerization. While this method ensures pure polymer formation, it can be challenging to manage the heat generated during the reaction, which may impact the stability of thermolabile active ingredients. Suspension polymerization, also known as pearl polymerization, operates at lower temperatures. Here, the monomer mixture, including the active drug, is heated with droplets dispersed in a continuous aqueous phase. Microspheres produced via suspension techniques typically have sizes less than 100 µm. Emulsion polymerization differs from suspension polymerization in that the initiator is in the aqueous phase. This method is also conducted at lower temperatures, utilizing water as the external phase. These techniques allow for faster polymer formation, although there is a risk of the polymer associating with unreacted monomers and other additives. Efficient heat dissipation is facilitated by the aqueous environment in both suspension and emulsion polymerization methods³⁰.

 

Interfacial polymerization:

This technique involves the reaction of various monomers at the interface between two immiscible liquid phases to form a polymer film that surrounds the dispersed phase. It utilizes two types of monomers: one dissolved in a continuous phase and the other dispersed in an aqueous continuous phase, where it forms emulsions. The resulting polymer's solubility in the emulsion droplets determines the structure of the microspheres. If the polymer is soluble in the droplets, it forms a monolithic carrier structure. Conversely, if the polymer is insoluble in the droplets, it creates a capsular structure around the dispersed phase. This method allows for precise control over the microsphere's morphology and properties, making it suitable for diverse applications in drug delivery systems, encapsulation, and controlled release technologies.

 

Spray drying:

These methods involve drying a mist of polymer and drug in air, distinguished by how solvent removal or solution cooling is managed: spray drying and spray congealing, respectively. Initially, the polymer is dissolved in a volatile organic solvent like dichloromethane or acetone. Solid drug forms are dispersed in this polymer solution using high-speed homogenization. The resulting dispersion is then atomized within a stream of hot air, where atomization produces small droplets or a fine mist. Rapid evaporation of the solvent from these droplets or mist instantly forms microspheres ranging in size from 1 to 100 µm.

 

The microspheres are separated from the hot air using a cyclone separator, and any remaining solvent traces are eliminated through vacuum drying. A key advantage of these processes is their ability to operate under aseptic conditions, ensuring the sterility of the produced microspheres³¹.

 

Solvent extraction:

In this method, microparticle preparation entails removing the organic phase by extracting the organic solvent, typically using a water-miscible solvent like isopropanol. The organic phase is eliminated by mixing with water, a process that accelerates the hardening of microspheres. Variations of this technique include directly adding drugs or proteins to the polymer organic solution. The rate of solvent removal through extraction depends on factors such as water temperature, the ratio of emulsion volume to water, and the polymer's solubility profile. Adjusting these parameters allows for precise control over the formation and properties of the microspheres, optimizing their suitability for various biomedical and pharmaceutical applications.

 

Preparation of Microspheres by Thermal Cross-Linking:

Citric acid was employed as a cross-linking agent in the preparation of microspheres using chitosan. Initially, a 30 ml aqueous acetic acid solution of chitosan was prepared with citric acid, maintaining a constant molar ratio between chitosan and citric acid. This chitosan-citric acid solution was cooled to 0°C and then added to a specific volume of corn oil also maintained at 0°C, with stirring for a defined duration. The resulting emulsion was subsequently introduced into corn oil heated to 120°C in a glass beaker, undergoing cross-linking under vigorous stirring at 1000 rpm for a set period. Following formation, the microspheres were filtered, washed with diethyl ether to remove residual components, and then dried before being sieved to achieve the desired size distribution. This method allows for the controlled production of chitosan-based microspheres suitable for various biomedical and pharmaceutical applications³².

 

EVALUATION OF MICROSPHERES:

Particle size and shape:

The most commonly used methods for visualizing microparticles are conventional light microscopy and scanning electron microscopy (SEM). These techniques are effective for examining the shape and surface structure of microparticles in detail. Conventional light microscopy is utilized along with calibrated eyepiece micrometers to measure particle size. This involves measuring the size of approximately 100 microspheres and calculating the average particle size. Light microscopy provides insights into the overall morphology and size distribution of microparticles. On the other hand, scanning electron microscopy (SEM) offers higher resolution and can reveal finer details of the surface morphology of microparticles. It is particularly useful for examining the surface characteristics, porosity, and structural integrity of the particles. Both microscopy techniques play crucial roles in characterizing microparticles, aiding in the assessment of their physical properties and suitability for various applications in pharmaceuticals, biomedical engineering, and materials science.

 

Where, n = number of microspheres checked; d = mean size

 

Density determination:

The density of microspheres is measured using a multi-volume pycnometer, beginning with an accurately weighed sample placed into a cup inside the device. Helium gas is then introduced at a constant pressure, causing it to expand and thereby lowering the pressure within the chamber. Consecutive pressure readings are taken at different initial pressures to calculate the volume occupied by the microspheres, including any void spaces. From these readings, the density of the microspheres is determined using the mass of the sample divided by its measured volume. This method provides precise measurements essential for evaluating the physical characteristics and applications of microspheres in fields such as drug delivery and materials science.

 

Isoelectric point:

By evaluating the electrophoretic mobility of microspheres and employing a microelectrophoresis equipment, the isoelectric point can be determined. Particle movement over a distance of 1 nm is measured to determine the mean velocity at various pH values between 3 and 10.

 

Electron spectroscopy for chemical analysis:

The surface chemistry of the microspheres can be ascertained by electron spectroscopy for chemical analysis, or ESCA. The method of determining the surface's atomic composition is made possible by ESCA. The surface degradation of the biodegradable microspheres can be ascertained from the spectra acquired using ECSA.

 

Drug entrapment efficiency:

Microspheres in measured amounts are extracted and crushed. After that, it was filtered after being dissolved in a buffer solution with a stirrer's assistance. A UV spectrophotometer was used to quantify and analyze the drug content using a calibration curve.

 

Swelling index:

It is ascertained by measuring the degree of microsphere swelling in a certain solvent. Five milligrams of dried microspheres are placed into five milliliters of buffer solution and left overnight in a measuring cylinder to reach the equilibrium swelling degree of the microspheres. The same is calculated using the provided formula³³.

 

Determination of percentage yield:

The measured amount of the product, the polymers utilized in the microspheres' formulation, and the total number of microspheres generated are added up to determine the % yield³⁴.

 

APPLICATIONS OF MICROSPHERES:

The illustrated exploration of the various applications of microspheres is in Figure 3.

 

The past successful attempts made on microspheres are as per Table 1.

 

 

Fig.3. Pharmaceutical applications of microsphere in drug delivery systems

 

 

 

Table 1: The past trials made on microspheres using quality by design indication of the polymers used and the responses

 

Table-1 cont……

 

CONCLUSION:

Microspheres represent a promising advancement in drug delivery systems, offering distinct advantages over other forms of medication delivery due to their unique properties, including precise control over drug release kinetics and targeted delivery. In this study, various preparation methods for microspheres are comprehensively examined, encompassing techniques such as single-emulsion, double-emulsion, solvent evaporation, and spray drying, among others. These methods allow for tailored formulations to match specific drug properties and delivery requirements. Furthermore, the study investigates the diverse applications of microspheres across therapeutic areas, including vaccine delivery, gene therapy, nasal administration, and oral delivery. Microspheres have demonstrated remarkable versatility in delivering medications with precise control over release profiles, positioning them as a promising platform for addressing medical challenges and improving patient outcomes. Looking ahead, ongoing advancements in formulation technology and a deeper understanding of drug delivery mechanisms suggest that microspheres will continue to play a pivotal role in advancing healthcare innovation.

 

REFERENCES:

1.   Ahad HA, Sreenivasulu R, Mallapu Rani E, Reddy BV. Preparation and evaluation of famotidine high density gastro retentive microspheres with synthetic and natural polymers. Journal of Pharmaceutical Education and Research. 2011; 2(1).

2.   Mundarinti SHB, Ahad HA. Impact of Pistacia lentiscus plant gum on particle size and swelling index in central composite designed amoxycillin trihydrate mucoadhesive microspheres. Indian Journal of Pharmaceutical Education and Research. 2023; 57:763-72.

3.   Sahu G, Sharma H, Kaur CD. A novel approach of magnetic modulated microspheres. Asian Journal of Pharmaceutical Research. 2013; 3(4):220-4.

4.   Sailaja K, Hindustan AA, Chinthaginjala H, Gudisipalli R, Sugali RI, Vagganagari Y. Approaches to creating and past successful attempts on microspheres: A primer for aspiring researchers. 2022.

5.   Harsha SS, Ahad HA, Haranath C, Dasari RR, Gowthami M, Varam NJ, et al. Exfoliation Technique of Composing and Depictions of Clopidogrel Bisulphate Afloat Microspheres. Journal of Evolution of Medical and Dental Sciences. 2020; 9(14):1156-61.

6.   Babu GN, Menaka M, Ahad HA. Neem Fruit Mucilage-Aided Mucoadhesive Microspheres of Acyclovir Using 32 Factorial Design With Design-Expert Software. 2022.

7.   Sri SR. Formulation and Evaluation of Nizatidine Microspheres. Research Journal of Science and Technology. 2019; 11(1):14-26.

8.   Babu GN, Menaka M, Ahad HA, Veerabomma S. In Vivo Pharmacokinetic Studies of Acyclovir Gastro Retentive Mucoadhesive Microspheres Aided by Azadirachta indica Fruit Mucilage. Research Journal of Pharmacy and Technology. 2023; 16(10):4554-8.

9.   Patel D, Shah SK, Tyagi CK. Design, formulation and characterization of microspheres containing mesalamine for the treatment of ulcerative colitis. Research Journal of Science and Technology. 2021; 13(3):165-9.

10. Mali AD, Bathe R. An Updated Review on Formulation and Evaluation of Microsponge. Research Journal of Topical and Cosmetic Sciences. 2015; 6(2):77-85.

11. Ahad HA, Haranath C, Rahul Raghav D, Gowthami M, Naga Jyothi V, Sravanthi P. Overview on recent optimization techniques in gastro retentive microcapsules by factorial design. Int J Pharm Sci Res. 2019; 10(9):247-54.

12. Shaik K, Ahad HA, Chinthaginjala H, Babafakruddin P, Lakunde J, Ksheerasagare T. Gas generating floating tablets: A quick literature review for the scholars. 2022.

13. Kshirsagar DS, Saudagar R. Microsphere: a review. Research Journal of Topical and Cosmetic Sciences. 2016; 7(1):27-37.

14. Shravani Y, Ahad HA, Haranath C, gari Poojitha B, Rahamathulla S, Rupasree A. Past Decade Work Done On Cubosomes Using Factorial Design: A Fast Track Information for Researchers. Int J Life Sci Pharma Res. 2021; 11(1): P124-35.

15. Kalaivani M, Pulikottil MJ, Mary B, Sakthivel R, Rajasekaran A. Preparation and Characterisation of Alginate Coated Chitosan Microspheres for Bacterial Vaccines. Research Journal of Pharmacy and Technology. 2010; 3(2):503-6.

16. Babu GN, Muthukarupan M, Ahad HA. Neem Fruit Mucilage Impact on Acyclovir Release at Different Intervals: A Central Composite Design Screening. International Journal of Pharmaceutical Research and Allied Sciences. 2021; 10(4).

17. Chinthaginjala H, Bogavalli V, Hindustan AA, Pathakamuri J, Pullaganti SS, Gowni A, et al. Nanostructured Lipid Carriers: A Potential Era of Drug Delivery Systems. Ind J Pharm Edu Res. 2024; 58(1): 21-33.

18. Ahad HA, Chinthaginjala H, Meharajunnisa B, Vandana N, Gudisipalli R, Nikhila P. Past Work Done on the Matrix Tablets: A Quick Reference for the Research Beginner in Sustained-release Dosage Forms. International Journal of Pharmaceutical Investigation. 2023; 13(3).

19. Becare Dkhar KM, Ahad HA, Sahani P, Syiemlieh P. Pushing Limits: Exploring Torsemide's Potential Through In-Vitro Mucoadhesive Buccal Delivery Characterization. Journal of Advanced Zoology. 2023; 44.

20. Ahad HA, Chinthaginjala H, Rahamtulla S, Pallavi BP, Shashanka C, Prathyusha J. A comprehensive report on solid dispersions by factorial design. 2021.

21. Shinde A, Bhise S. Optimization of Pharmacokinetic By Loading Bioenhancer in Optimized Nasal Mucoadhesive Microspheres of Insulin. Research Journal of Pharmacy and Technology. 2010; 3(2):613-8.

22. Kumar YB, Ahad HA, Haranath C, Sumanth G, Pasupuleti DS, Reddy SS. Platelet Rich Plasma Therapy: A quick note for every health care professional. Int J Life Sci Pharma Res. 2020; 10(5): P84-9.

23. Yadav AV, Yadav VB. Clarithromycin Floating Microspheres with Calcium Silicate by Using Emulsion Solvent Diffusion System (ESDS). Research Journal of Pharmacy and Technology. 2010; 3(3):784-91.

24. Ahad HA, Haranath C, Tarun K, Krishna JV, Chandana N, Indrani B. Immuno-boosters as health accelerants to tackle viral infections. Asian Journal of Pharmaceutical Research. 2021; 11(3):212-6.

25. Anusha G, Ahad H, Haranath C, Suryaprakash R, Kalpana K. A technical view on transporters-the drug pharmacokinetics dictators. MOJ Bioequiv Availab. 2019; 9: 47-52.

26. Ahad HA, Ksheerasagare T, Chelluru A, Haranath C, Reddy GSP, Krishna JV. Herbal Mucilage attempted as a Super disintegrating agent in Oral Disintegrating Tablets. Research Journal of Pharmacy and Technology. 2020; 13(11): 5489-92.

27. Ahad HA, Haranath C, Kumar BP, Roy D, Dharani BHS, Ayisha MU. A desk top allusion to the rare orphan diseases and orphan drugs: possessions to discern by every healthcare professional. 2021.

28. Swetha T, Ahad HA, Reddy KK, Sekhar A, Sivaji S, Kumar B. Formulation and in-vitro permeation studies of Ketoprofen-Ficus reticulata fruit mucilage transdermal patches. Der Pharmacia Lettre. 2010; 2(6): 190-9.

29. Annepogu H, Hindustan A, Devanna N. Assessing the best polyvinyl pyrrolidone as a carrier for Etoricoxib solid Dispersions: fabrication and evaluation. J Pharm Sci Innov. 2018; 7: 208-14.

30. Dhadde GS, Mali HS, Raut ID, Nitalikar MM, Bhutkar MA. A review on microspheres: Types, method of preparation, characterization and application. Asian Journal of Pharmacy and Technology. 2021; 11(2):149-55.

31. Gurung BD, Kakar S. An overview on microspheres. Int J Health Clin Res. 2020; 3(1):11-24.

32. Kakkar V, Wani S, Gautam SP, Qadrie ZL. Role of microspheres in novel drug delivery systems: preparation methods and applications. International Journal of Current Pharmaceutical Research. 2020; 12(3):10-5.

33. Denkbaş EB, Kilicay E, Birlikseven C, Öztürk E. Magnetic chitosan microspheres: preparation and characterization. Reactive and Functional Polymers. 2002; 50(3):225-32.

34. Sahil K, Akanksha M, Premjeet S, Bilandi A, Kapoor B. Microsphere: A review. Int J Res Pharm Chem. 2011; 1(4): 1184-98.

35. Singhal MP. Sapindus Mukorossi Fruits Gum as Sustained Release Carrier: Optimization of Gastroretentive Drug Delivery System using Simplex Lattice Design. Asian Journal of Pharmaceutics (AJP). 2018; 12(1).

36. Mundarinti S, Ahad HA. Past decade attempts on gastro retentive microspheres using factorial design: A comprehensive literature. Int J Pharm Phytopharmacol Res. 2021; 11:24-30.

37. Patel RS. Formulation and evaluation of Multiparticulate systems of propranolol hydrochloride for controlled release: Rajiv Gandhi University of Health Sciences (India); 2006.

38. Wang L, Liu C, Lu W, Xu L, Kuang L, Hua D. ROS-sensitive Crocin-loaded chitosan microspheres for lung targeting and attenuation of radiation-induced lung injury. Carbohydrate Polymers. 2023; 307: 120628.

39. Raymond G, Degennaro M, Mikeal R. Preparation of gelatin: Phenytoin sodium microsphers: An in vitro and in vivo Evaluation. Drug Development and Industrial Pharmacy. 1990; 16(6): 1025-51.

40. Sevgi F, Kaynarsoy B, Ertan G. An anti-inflammatory drug (mefenamic acid) incorporated in biodegradable alginate beads: development and optimization of the process using factorial design. Pharmaceutical Development and Technology. 2008; 13(1):5-13.

41. Li Q, Sun L-J, Gong X-F, Wang Y, Zhao X-L. Simultaneous optimization of multiple response variables for the gelatin-chitosan microcapsules containing Angelica essential oil. Iranian Journal of Pharmaceutical Research. 2017; 16(1):50.

42. Mokale V, Jitendra N, Yogesh S, Gokul K. Chitosan reinforced alginate controlled release beads of losartan potassium: design, formulation and in vitro evaluation. Journal of Pharmaceutical Investigation. 2014; 44:243-52.

43. Takka S, Ocak ÖH, Acartürk F. Formulation and investigation of nicardipine HCl–alginate gel beads with factorial design-based studies. European Journal of Pharmaceutical Sciences. 1998; 6(3):241-6.

44. Shukla RK, Tiwari A. Design and development of microparticulate delivery system of metronidazole: Experimental design methodology. Journal of Applied Polymer Science. 2012; 126(1):304-14.

45. Aberturas M, Molpeceres J, Guzman M, Garcia F. Development of a new cyclosporine formulation based on poly (caprolactone) microspheres. Journal of Microencapsulation. 2002; 19(1):61-72.

46. Jaswir I, Noviendri D, Taher M, Mohamed F, Octavianti F, Lestari W, et al. Optimization and formulation of fucoxanthin-loaded microsphere (F-LM) using response surface methodology (RSM) and analysis of its fucoxanthin release profile. Molecules. 2019; 24(5):947.

47. Hamed SF, Hashim AF, Hamid HAA, Abd-Elsalam KA, Golonka I, Musiał W, et al. Edible alginate/chitosan-based nanocomposite microspheres as delivery vehicles of omega-3 rich oils. Carbohydrate Polymers. 2020; 239:116201.

48. Shah PP, Mashru RC, Rane YM, Thakkar A. Design and optimization of mefloquine hydrochloride microparticles for bitter taste masking. AAPS Pharmscitech. 2008; 9:377-89.

49. Kharb V, Saharan VA, Dev K, Jadhav H, Purohit S. Formulation, evaluation and 32 full factorial design-based optimization of ondansetron hydrochloride incorporated taste masked microspheres. Pharmaceutical Development and Technology. 2014; 19(7): 839-52.

50. Nagpal M, Maheshwari D, Rakha P, Dureja H, Goyal S, Dhingra G. Formulation development and evaluation of alginate microspheres of ibuprofen. Journal of Young Pharmacists. 2012; 4(1): 13-6.

51. Abbas Z, Marihal S. Gellan gum-based mucoadhesive microspheres of almotriptan for nasal administration: Formulation optimization using factorial design, characterization, and: in vitro: evaluation. Journal of Pharmacy and Bioallied Sciences. 2014; 6(4): 267-77.

52. Zaghloul A, Vaithiyalingam S, Faltinek J, Reddy I, Khan M. Response surface methodology to obtain naproxen controlled release tablets from its microspheres with Eudragit L100-55. Journal of Microencapsulation. 2001; 18(5):651-62.

53. Gabbay Alves TV, Silva da Costa R, Aliakbarian B, Casazza AA, Perego P, Carrera Silva Junior JO, et al. Microencapsulation of Theobroma cacao L. waste extract: optimization using response surface methodology. Journal of Microencapsulation. 2017; 34(2):111-20.

54. Przybysz MA, Szterk A, Symoniuk E, Gaszczyk M, Dluzewska E. Alpha-and beta-carotene stability during storage of microspheres obtained from spray-dried microencapsulation technology. Polish Journal of Food and Nutrition Sciences. 2018; 68(1).

55. Alkhatib H, Mohamed F, Akkawi ME, Alfatama M, Chatterjee B. Microencapsulation of black seed oil in alginate beads for stability and taste masking. Journal of Drug Delivery Science and Technology. 2020; 60:102030.

56. Elsayed MM. Controlled release alginate-chitosan microspheres of tolmetin sodium prepared by internal gelation technique and characterized by response surface modeling. Brazilian Journal of Pharmaceutical Sciences. 2020; 56:e18414.

57. Rai S, Ravikumar P. Development and evaluation of microsphere based topical formulation using design of experiments. Indian Journal of Pharmaceutical Sciences. 2016; 78(2):182-92.

58. Mennini N, Furlanetto S, Cirri M, Mura P. Quality by design approach for developing chitosan-Ca-alginate microspheres for colon delivery of celecoxib-hydroxypropyl-β-cyclodextrin-PVP complex. European Journal of Pharmaceutics and Biopharmaceutics. 2012; 80(1):67-75.

59. Pardeshi CV, Rajput PV, Belgamwar VS, Tekade AR. Formulation, optimization and evaluation of spray-dried mucoadhesive microspheres as intranasal carriers for Valsartan. Journal of Microencapsulation. 2012; 29(2):103-14.

60. Nila M, Sudhir M, Cinu T, Aleykutty N, Jose S. Floating microspheres of carvedilol as gastro retentive drug delivery system: 32 full factorial design and in vitro evaluation. Drug Delivery. 2014; 21(2):110-7.

61. Kumal VB, Thapa C, Ghimire P, Chaudhari P, Yadhav J. Formulation and optimization of Enalapril Maleate-loaded floating microsphere using Box–Behnken design: in vitro study. Journal of Applied Pharmaceutical Science. 2020; 10(8):095-104.

62. Gohel M, Amin AF. Formulation optimization of controlled release diclofenac sodium microspheres using factorial design. Journal of Controlled Release. 1998; 51(2-3):115-22.

63. Deshmukh RK, Naik JB. Aceclofenac microspheres: Quality by design approach. Materials Science and Engineering: C. 2014; 36:320-8.

64. El-Say KM, El-Helw A-RM, Ahmed OA, Hosny KM, Ahmed TA, Kharshoum RM, et al. Statistical optimization of controlled release microspheres containing cetirizine hydrochloride as a model for water soluble drugs. Pharmaceutical Development and Technology. 2015; 20(6):738-46.

65. Abdalla KF, Kamoun EA, El Maghraby GM. Optimization of the entrapment efficiency and release of ambroxol hydrochloride alginate beads. Journal of Applied Pharmaceutical Science. 2015; 5(4): 13-9.

66. Swain S, Behera UA, Beg S, Sruti J, Patro CN, Dinda S, et al. Design and characterization of enteric-coated controlled release mucoadhesive microcapsules of rabeprazole sodium. Drug Development and Industrial Pharmacy. 2013; 39(4):548-60.

67. Khattab I, Bandarkar F, Lila A. Formulation and optimization of sustained release terbutaline sulfate microspheres using response surface methodology. Drug Discoveries and Therapeutics. 2009; 3(3).

68. Li G-y, Zhong M, Zhong Y-d, Ding P, Huang Y. Formulation optimization of chelerythrine loaded O-carboxymethylchitosan microspheres using response surface methodology. International Journal of Biological Macromolecules. 2011; 49(5):970-8.

69. Gaur PK, Mishra S, Kumar A, Panda BP. Development and optimization of gastroretentive mucoadhesive microspheres of gabapentin by Box–Behnken design. Artificial cells, Nanomedicine, and Biotechnology. 2014; 42(3):167-77.

70. Sultana S, Bhavna, Iqbal Z, Panda B, Talegaonkar S, Bhatnagar A, et al. Lacidipine encapsulated gastroretentive microspheres prepared by chemical denaturation for pylorospasm. Journal of Microencapsulation. 2009; 26(5):385-93.

71. Jabar A, Madni A, Bashir S, Tahir N, Usman F, Rahim MA, et al. Statistically optimized pentazocine loaded microsphere for the sustained delivery application: Formulation and characterization. PloS One. 2021; 16(4):e0250876.

72. Trivedi R, Shah S. Formulation and Evaluation of Mucoadhesive Nasal Microspheres of Hydralazine Hydrochloride. The Journal of Medical Research. 2018.

 

 

Received on 15.02.2024      Revised on 08.07.2024 Accepted on 23.10.2024      Published on 10.12.2024 Available online on December 17, 2024 Asian J. Res. Pharm. Sci. 2024; 14(4):391-400. DOI: 10.52711/2231-5659.2024.00062 ©Asian Pharma Press All Right Reserved
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.